Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gland Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10931
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized products, glycosominoglycans molecules, high-potent drugs, and long-acting suspensions. It offers tartrate and timolol ophthalmic solutions and suspensions, ophthalmic emulsion, heparin, antibodies, hydrochloride ophthalmic solutions, anesthetic products, critical cardiology products, critical care products, anti infective and gastrointestinal products. Gland Pharma’s services include contract development and manufacturing, clinical batch manufacturing, and others. The company also provides synthesis of complex drug molecules such as low molecular weight heparins and anti-cancer drugs. It has its facilities in Hyderabad and Visakhapatnam; India. Gland Pharma is headquartered in Hyderabad, Telangana, India.

Gland Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gland Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gland Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 12
Partnerships 13
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 13
Dr. Reddy’s Labs Enters into Co-Marketing Agreement with Gland Pharma 14
Licensing Agreements 15
Athenex to Enter into Licensing Agreement with Gland Pharma 15
Athenex to Enter into Licensing Agreement with Gland Pharma 16
Equity Offering 17
Gland Pharma May Raise USD500 Million in IPO 17
Acquisition 18
Shanghai Fosun Pharma Acquires 74% Stake in Gland Pharma for USD1.1 Billion 18
Gland Pharma Ltd – Key Competitors 20
Gland Pharma Ltd – Key Employees 21
Gland Pharma Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gland Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gland Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Gland Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 12
Breckenridge Pharma Enters into Marketing Agreement with Gland Pharma 13
Dr. Reddy’s Labs Enters into Co-Marketing Agreement with Gland Pharma 14
Athenex to Enter into Licensing Agreement with Gland Pharma 15
Athenex to Enter into Licensing Agreement with Gland Pharma 16
Gland Pharma May Raise USD500 Million in IPO 17
Shanghai Fosun Pharma Acquires 74% Stake in Gland Pharma for USD1.1 Billion 18
Gland Pharma Ltd, Key Competitors 20
Gland Pharma Ltd, Key Employees 21

List of Figures
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gland Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gland Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norddeutsche Landesbank Girozentrale:企業のM&A・提携動向(エネルギー分野)
    Summary Norddeutsche Landesbank Girozentrale (NORD/LB) is a financial services provider that operates in retail, corporate, structured finance and public sectors. The company offers electronic banking, private banking, agricultural banking, individual advice, savings, accounts, call money accounts, …
  • Jindal Poly Films Limited (JINDALPOLY):企業の財務及び戦略的SWOT分析
    Summary Jindal Poly Films Limited (JPFL) a subsidiary of B.C. Jindal Group is a chemical company that provides polyester products. The company manufactures and markets polyester film, polypropylene film, steel pipes and photographic products. Its products include PET films, BOPP films, metallised fi …
  • Horizon Discovery Group Plc (HZD):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers se …
  • Tribune Media Company:企業のM&A・提携・投資分析
    Tribune Media Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tribune Media Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • New Look Retail Group Limited:企業の戦略・SWOT・財務情報
    New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary New Look Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ray Sigorta A.S. (RAYSG):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Ray Sigorta A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • UTair Aviakompaniya OAO:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' UTair Aviakompaniya OAO Mergers …
  • Daetwyler Holding AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Daetwyler Holding AG Mergers an …
  • Mediobanca Banca di Credito Finanziario S.p.A.:企業のM&A・提携・投資分析
    Mediobanca Banca di Credito Finanziario S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mediobanca Banca di Credito Finanziario S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • SandRidge Energy, Inc. (SD):石油・ガス:M&Aディール及び事業提携情報
    Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, the company operates assets in Oklahoma and Kansas. In Rockies, SandRidge operates assets within t …
  • BDO International Limited:企業の戦略・SWOT・財務情報
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bharat Electronics Limited:企業の戦略・SWOT・財務情報
    Bharat Electronics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Electronics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ECO Animal Health Group Plc (EAH):企業財務及び戦略的SWOT分析
    Summary ECO Animal Health Group Plc (ECO) is a veterinary products company that develops therapeutic products. The company develops and markets pharmaceutical products and chemicals for animal health markets. It produces proprietary patented drugs that are used for treatment of respiratory and enter …
  • Kathmandu Holdings Limited:企業の戦略・SWOT・財務情報
    Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Kathmandu Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Thornton & Ross Ltd:企業のM&A・提携動向(医療分野)
    Summary Thornton & Ross Ltd (Thornton and Ross), a subsidiary of Stada Arzneimittel AG is a pharmaceutical company that develops and supplies medicines and healthcare products. The company manufactures over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and …
  • Obtala Resources Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Obtala Resources Limited Merger …
  • NV Nederlandse Spoorwegen:企業の戦略・SWOT・財務情報
    NV Nederlandse Spoorwegen - Strategy, SWOT and Corporate Finance Report Summary NV Nederlandse Spoorwegen - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • IBEX Technologies Inc. (IBT):企業概要、財務及び戦略的SWOT分析
    Summary IBEX Technologies Inc. (IBEX) is a biopharmaceutical company. The company markets recombinant high-purity proprietary enzymes from flavobacterium heparinum. Its enzymes include heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. IBEX offers cartilage degradat …
  • Columbia University-医療機器分野:企業M&A・提携分析
    Summary Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆